Savara

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.

About SVRA

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. 

CEO
Matthew Pauls
CEOMatthew Pauls
Employees
37
Employees37
Headquarters
Langhorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded
1995
Founded1995
Employees
37
Employees37

SVRA Key Statistics

Market cap
687.98M
Market cap687.98M
Price-Earnings ratio
-14.89
Price-Earnings ratio-14.89
Dividend yield
Dividend yield
Average volume
570.19K
Average volume570.19K
High today
$5.03
High today$5.03
Low today
$4.85
Low today$4.85
Open price
$4.88
Open price$4.88
Volume
904.12K
Volume904.12K
52 Week high
$5.70
52 Week high$5.70
52 Week low
$1.63
52 Week low$1.63

SVRA News

Yahoo Finance 7d
Savara Announces New Employment Inducement Grant - Yahoo Finance

AUSTIN, Texas, March 22, 2024--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, tod...

Savara Announces New Employment Inducement Grant - Yahoo Finance

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.